| 摘要 |
Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio. |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;HOFFMANN-LA ROCHE INC.;THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
发明人 |
BOBADILLA, MARIA;BADI, LAURA;DUCHATEAU-NGUYEN, GUILLEMETTE;ESSIOUX, LAURENT;LANGEN, HANNO;MAGNONE, MARIA CHIARA;SCHINDLER, THOMAS;THIER, MARTINA;FORMENTINI, IVAN;DURAN PACHECO, GONZALO CHRISTIAN;SOLIER, CORINNE;KRETZLER, MATTHIAS;NAIR, VIJI;JU, WENJU |
